Dry Eye Disease
Covers a range of topics, including clinical assessment, pathophysiology, the link between dry eye and system disease, and the use of FDA and off-label products as treatment options for dry eye diseases.
Includes a section devoted to the presence of dry eye disease in specific populations, including patients presenting with other ocular conditions, systemic pain conditions, graft-versus-host disease, Sjögren's syndrome, and meibomian gland dysfunction.
Addresses the challenges associated with treating ocular pain not responsive to traditional dry eye disease treatments.
Features concise chapters from a team of international chapter authors, providing global perspectives on this common disorder.
Consolidates today's available information on this timely topic into a single, convenient resource
|Table of Content||
Section 1: What is Dry Eye Disease (DED)?
What is Dry Eye Disease: Evolving Definitions and Epidemiology
Questionnaires Used to Assess Dry Eye Disease
Clinical Assessment of Dry Eye Disease: Tear Film and Ocular Surface Health
Clinical Assessment of Dry Eye Disease: Nerve Health
Pathophsiology of Dry Eye Disease using Animal Models
Pathophsiology of Dry Eye Disease using Human Models
Section 2: Dry Eye Disease (DED) in Specific Populations
Sjögrens and Dry Eye Disease
Graft versus Host and Dry Eye Disease
Meibomian Gland Dysfunction and Dry Eye Disease
Systemic Pain Conditions and Dry Eye Disease
Ocular Conditions and Dry Eye Disease
Section 3: Treatment of Dry Eye Disease (DEF)
Treatment of Dry Eye Disease in the United States
Treatment of Dry Eye Disease in Asia
Treatment of Dry Eye Disease in Europe
Treatment of Ocular Pain Not Responsive to Traditional Dry Eye Disease Treatments
|Author Information||Edited by Anat Galor, MD, MSPH, Associate Professor of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, Florida|
|Trim||235 x 191 (7 1/2 x 9 1/4)|
|Stock Status||Please allow 2 - 3 weeks for delivery|